Related Experiment Video

Updated: Jun 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary

Julio Marchini1, David Morrow, Frederic Resnic

  • 1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Critical Pathways in Cardiology
|December 2, 2010
PubMed

Insights

This study presents an algorithm for using Prasugrel (Effient) in patients undergoing cardiac procedures. The algorithm aligns with current standards and TRITON-TIMI 38 trial data, focusing on patient selection and benefits over clopidogrel.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) requires effective antiplatelet therapy.
  • Prasugrel (Effient) has shown efficacy in acute coronary syndrome (ACS) patients.
  • Optimizing antiplatelet strategies is crucial for procedural success and patient outcomes.

Purpose of the Study:

  • To present a novel algorithm for the clinical use of Prasugrel (Effient) in patients undergoing cardiac catheterization and PCI.
  • To ensure the algorithm aligns with established standards of care and pivotal trial data.
  • To guide the appropriate selection of patients for Prasugrel treatment and analyze its benefits over clopidogrel.

Main Methods:

  • Algorithm development based on data from the TRITON-TIMI 38 trial.
  • Comparison of Prasugrel versus clopidogrel in ACS patients undergoing PCI.
  • Focus on clinical decision-making for Prasugrel initiation and management.

Main Results:

  • The proposed algorithm is consistent with published standards of care.
  • It incorporates findings from the TRITON-TIMI 38 trial comparing Prasugrel and clopidogrel.
  • The algorithm emphasizes patient selection for optimal Prasugrel benefit.

Conclusions:

  • The developed algorithm provides a framework for Prasugrel use in PCI patients.
  • It aims to optimize antiplatelet therapy by leveraging evidence from major clinical trials.
  • Effective patient selection is key to maximizing the benefits of Prasugrel in ACS patients undergoing PCI.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...